|
Number
|
Title
|
First Author
|
|
LB-0005
|
12 months Primary Outcome from a Prospective Patient-level Pooled Analysis of the Novel Thinner Strut Firesorb Sirolimus-eluting Bioresorbable Scaffold for the Treatment of De novo Coronary Artery Disease
|
Jian'an Wang
|
|
LB-0006
|
A prospective, multi-center, blinded, randomized controlled trial of the safety and effectiveness of the Iberis® multi-electrode renal artery radiofrequency ablation catheter system for the treatment of primary hypertension (Iberis-HTN)
|
Runlin Gao
|
|
LB-0008
|
Clinical performance of a novel hybrid IVUS-OCT system: a multicenter, randomised, non-inferiority trial (PANOVISION)
|
Haibo Jia
|
|
LB-0009
|
Pivotal trial of targeted renal denervation to treat hypertension: SMART Study
|
Jie Wang
|
|
LB-0011
|
Effectiveness and safety of a novel intravascular shockwave lithotripsy system for severe coronary calcification: The SHATTER trial
|
Qiuhe Wang
|
|
LB-0012
|
A Randomized Controlled Clinical Trial of Prolonged Stent Deployment Stagey in Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction
|
Rutao Wang
|
|
LB-0013
|
Application of man-machine coupling innovative technology in secondary prevention management of patients with coronary heart disease after PCI
|
Xiao Fan Yu
|
|
LB-0015
|
Prognostic value of machine-learning-based PRAISE score for ischemic and bleeding events in patients with acute coronary syndrome undergoing PCI
|
Hao-yu Wang
|
|
LB-0016
|
Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: a multicentre, randomised, sham-controlled trial
|
Lei Song
|
|
LB-0017
|
" Quantitative flow ratio as a continuous predictor of myocardial infarction"
|
Changdong Guan
|
